share_log
Moomoo 24/7 ·  Mar 20 08:35
NLS Pharmaceutics Shares Are Trading Higher After the Company Announced an Exclusive Worldwide License Agreement With Aexon Labs, Which Grants the Company the Opportunity to Acquire Global Development and Commercialization Rights to Aexon's Dual Orexin Receptor Agonists Platform
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment